When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Following through on its previously announced strategy to focus its resources on its immuno-inflammatory pipeline, Aclaris Therapeutics (NASDAQ:ACRS) has agreed to sell global rights to rosacea topical cream RHOFADE (oxymetazoline) to EPI Health, LLC.
More news on: Aclaris Therapeutics, Inc., Healthcare stocks news,